Literature DB >> 21432519

Stimulation of hydrogen peroxide production by drinking water contaminants in HL-60 cells sensitized by retinoic acid.

H Yoshida1, S Inoue, K Yoshida, O Nakajima, S Mizuno.   

Abstract

Chemical carcinogens, such as chloroform and trichloroethylene, are present in drinking water in Japan. As these contaminants are believed to have a role in carcinogenesis, we examined if chloroform and trichloroethylene, as well as methylene chloride, xylene, benzene, and ethanol, have the ability to generate hydrogen peroxide (H(2)O(2)) in human polymorphonuclear leukocytes (PMN) and human leukemia (HL-60) cells. Methylene chloride, benzene, xylene, trichloroethylene, and ethanol did not increase cellular H(2)O(2): production as measured by flow cytometry nor as observed by confocal laser microscopy. In PMN and RAuntreated HL-60 cells chloroform did not significantly affect H(2)O(2) levels. However, in HL-60 cells sensitized by pretreatment of 10 nM retinoic acid (RA) for 12 h, chloroform induced a significant increase in H(2)O(2), but the increase induced by trichloroethylene was not significant. The observed increase in fluorescence was confirmed using a confocal laser microscope. These results indicate that chloroform and trichloroethylene may stimulate H(2)O(2) production in HL60 cells sensitized by pretreatment of RA. Our method may be useful to test if weak stimulants can stimulate intracellular H(2)O(2) production.

Entities:  

Keywords:  Carcinogenicity; Differentiated leukemia cell; Flow cytometry; Hydrogen peroxide; Retinoic acid

Year:  1998        PMID: 21432519      PMCID: PMC2723339          DOI: 10.1007/BF02931793

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  26 in total

1.  Trihalomethanes in chlorinated drinking water of Cairo, Egypt.

Authors:  M A el-Dib; R K Ali
Journal:  Bull Environ Contam Toxicol       Date:  1992-03       Impact factor: 2.151

Review 2.  The possible role of free radical reactions in carcinogenesis.

Authors:  H B Demopoulos; D D Pietronigro; E S Flamm; M L Seligman
Journal:  J Environ Pathol Toxicol       Date:  1980-03

3.  A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

4.  Stimulation and priming of human neutrophils by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: qualitative and quantitative differences.

Authors:  A Yuo; S Kitagawa; A Ohsaka; M Saito; F Takaku
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

5.  Induction of granulocytic maturation in HL-60 human leukemia cells by free radicals: a hypothesis of cell differentiation involving hydroxyl radicals.

Authors:  K Nagy; G Pásti; L Bene; I Zs-Nagy
Journal:  Free Radic Res Commun       Date:  1993

6.  The contribution of electrophilic and radicalic intermediates to phospholipid adducts formed by halomethanes in vivo.

Authors:  V De Curtis; S Gemma; M Sbraccia; E Testai; L Vittozzi
Journal:  J Biochem Toxicol       Date:  1994-12

Review 7.  Free radicals as carcinogens and their quenchers as anticarcinogens.

Authors:  L Santamaria; A Bianchi-Santamaria
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

8.  Radiation chemical mechanisms of single- and double-strand break formation in irradiated SV40 DNA.

Authors:  R E Krisch; M B Flick; C N Trumbore
Journal:  Radiat Res       Date:  1991-05       Impact factor: 2.841

9.  Tamoxifen suppresses tumor promoter-induced hydrogen peroxide formation by human neutrophils.

Authors:  J S Lim; K Frenkel; W Troll
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

10.  Growth control or terminal differentiation: endogenous production and differential activities of vitamin A metabolites in HL-60 cells.

Authors:  T M Eppinger; J Buck; U Hämmerling
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.